Literature DB >> 22653077

Adopting integrated care pathways in non-small-cell lung cancer: from theory to practice.

Gianpiero Fasola1, Simona Rizzato, Valentina Merlo, Marianna Aita, Tino Ceschia, Francesco Giacomuzzi, Emilio Lugatti, Stefano Meduri, Angelo Morelli, Maurizio Rocco, Valeria Tozzi.   

Abstract

INTRODUCTION: Integrated care pathways (ICPs) have been proposed as effective strategies for quality improvement. To date, limited data are available that detail the methodology to design an optimal care pathway for patients with non-small-cell lung cancer (NSCLC). The main aim of this study was to assess the quality of health care delivered to lung cancer patients referred to a hub university hospital.
METHODS: All professionals involved with the management of NSCLC patients, in cooperation with health care researchers, identified 11 quality indicators and associated benchmarks. These were used to estimate the quality and efficiency of health care delivered to a cohort of 175 NSCLC patients.
RESULTS: The gap between "desired" and "actual" performance has been measured by benchmarking current practice against key quality indicators. Diagnostic workup, multidisciplinary team care and medical treatment of advanced disease have emerged as areas of good performance. Conversely, the management of early-stage disease offers room for improvement, in terms of both accuracy of nodal staging and surgical timeliness.
CONCLUSIONS: Analyzing the process of caring for NSCLC patients is feasible and offers room for improvement. Acquired knowledge may be shared with hospital administrators, guide the revision of ICPs, and enable the delivery of consistent, high-quality clinical standards.

Entities:  

Mesh:

Year:  2012        PMID: 22653077     DOI: 10.1097/JTO.0b013e318257fbfe

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN: 1556-0864            Impact factor:   15.609


  7 in total

1.  A Design Methodology for Medical Processes.

Authors:  Simona Ferrante; Stefano Bonacina; Giuseppe Pozzi; Francesco Pinciroli; Sara Marceglia
Journal:  Appl Clin Inform       Date:  2016-03-30       Impact factor: 2.342

2.  Exploring Experiences of Survivors and Caregivers Regarding Lung Cancer Diagnosis, Treatment, and Survivorship.

Authors:  Margaret I Fitch
Journal:  J Patient Exp       Date:  2019-04-08

3.  Optimal Care Pathways for People with Lung Cancer- a Scoping Review of the Literature.

Authors:  Zulfiquer Otty; Amy Brown; Sabe Sabesan; Rebecca Evans; Sarah Larkins
Journal:  Int J Integr Care       Date:  2020-09-28       Impact factor: 5.120

4.  Indicators of guideline-concordant care in lung cancer defined with a modified Delphi method and piloted in a cohort of over 5,800 cases.

Authors:  Anita Andreano; Maria Grazia Valsecchi; Antonio Giampiero Russo; Salvatore Siena
Journal:  Arch Public Health       Date:  2021-01-25

5.  How the COVID-19 Pandemic Impacted on Integrated Care Pathways for Lung Cancer: The Parallel Experience of a COVID-Spared and a COVID-Dedicated Center.

Authors:  Giulia Pasello; Jessica Menis; Sara Pilotto; Stefano Frega; Lorenzo Belluomini; Federica Pezzuto; Anna Caliò; Matteo Sepulcri; Nunzia Luna Valentina Cernusco; Marco Schiavon; Maurizio Valentino Infante; Marco Damin; Claudio Micheletto; Paola Del Bianco; Riccardo Giovannetti; Laura Bonanno; Umberto Fantoni; Valentina Guarneri; Fiorella Calabrese; Federico Rea; Michele Milella; PierFranco Conte
Journal:  Front Oncol       Date:  2021-06-28       Impact factor: 6.244

6.  Timeliness of Diagnosing Lung Cancer: Number of Procedures and Time Needed to Establish Diagnosis: Being Right the First Time.

Authors:  Akash Verma; Albert Y H Lim; Dessmon Y H Tai; Soon Keng Goh; Ai Ching Kor; Dokeu Basheer A A; Akhil Chopra; John Abisheganaden
Journal:  Medicine (Baltimore)       Date:  2015-07       Impact factor: 1.817

7.  Looking through the eyes of the multidisciplinary team: the design and clinical evaluation of a decision support system for lung cancer care.

Authors:  Jon R Pluyter; Igor Jacobs; Sander Langereis; David Cobben; Sharon Williams; Jeannine Curfs; Ben van den Borne
Journal:  Transl Lung Cancer Res       Date:  2020-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.